Quantification of SPIO nanoparticles using phase gradient mapping.

Area of Science:

• Biomedical Imaging
• Medical Physics
• Nanotechnology

Background:

• Super-paramagnetic iron oxide (SPIO) nanoparticles are widely used as contrast agents in magnetic resonance imaging (MRI).
• Accurate quantification of SPIO concentration is crucial for effective diagnostic and therapeutic applications.
• Existing quantification methods, such as relaxivity-based approaches, have limitations.

Purpose of the Study:

• To develop and validate a new, accurate method for quantifying SPIO contrast agent concentration using MRI.
• To compare the performance of the proposed method against established relaxivity-based techniques.

Main Methods:

• A novel positive contrast method, phase gradient mapping (PGM), was employed to determine the gradient of the magnetic field map.
• SPIO concentration was calculated by fitting the field map gradient to an ideal geometric model.
• The method was validated using MRI experiments on phantoms with known SPIO concentrations.

Main Results:

• The phase gradient mapping (PGM) method demonstrated high accuracy in quantifying SPIO concentration.
• Results obtained from the PGM method showed excellent agreement with the true SPIO concentrations in phantom studies.
• The proposed method provides a reliable alternative to relaxivity-based SPIO quantification.

Conclusions:

• The developed phase gradient mapping (PGM) method offers a robust and accurate approach for SPIO contrast agent quantification in MRI.
• This technique has the potential to improve the precision of SPIO-based MRI diagnostics and research.
• Further studies can explore the application of PGM in in vivo SPIO concentration measurements.